dactinomycin has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Doleh, SM; Abuthawabeh, R; Al-Ali, S; Al-Tarawneh, SF; Alyami, H; Dahmash, EZ; Iyire, A | 1 |
1 other study(ies) available for dactinomycin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Mechanistic modelling of targeted pulmonary delivery of dactinomycin iron oxide-loaded nanoparticles for lung cancer therapy.
Topics: Administration, Inhalation; Alginates; Chitosan; COVID-19; Dactinomycin; Drug Delivery Systems; Humans; Lung; Lung Neoplasms; Nanoparticles; Respiratory Aerosols and Droplets | 2022 |